In vitro activity of 79 antimicrobial agents against Corynebacterium group D2 | Zendy

J.Á. García-Rodríguez | Zendy; José Elías García Sánchez | Zendy; Juan Luis Muñoz Bellido | Zendy; Teresa Nebreda-Mayoral | Zendy; E García Sánchez | Zendy; María Inmaculada GarcíaGarcía | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activity of 79 antimicrobial agents against Corynebacterium group D2

Author(s) -

J.Á. García-Rodríguez,

José Elías García Sánchez,

Juan Luis Muñoz Bellido,

Teresa Nebreda-Mayoral,

E García Sánchez,

María Inmaculada GarcíaGarcía

Publication year - 1991

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.35.10.2140

Subject(s) - teicoplanin , antimicrobial , microbiology and biotechnology , glycopeptide , vancomycin , corynebacterium , antibiotics , doxycycline , ofloxacin , biology , staphylococcus aureus , bacteria , ciprofloxacin , genetics

Corynebacterium group D2 (CGD2) is involved in urinary tract infections in patients with underlying predisposing factors. This microorganism is highly resistant to a number of antimicrobial agents. We tested the activities of 79 antimicrobial agents against CGD2. beta-Lactams, aminoglycosides, and macrolides were ineffective. Fluorinated quinolones showed irregular activities, ofloxacin being the most active one. Doxycycline, rifampin, and mainly glycopeptides (vancomycin and teicoplanin) were the most active antibiotics against CGD2.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research